Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Novel Non-Invasive Liver Fibrosis Tests Are Effective Biopsy Alternatives
February 2026
Novel non-invasive liver disease assessments (NILDAs) are effective liver biopsy alternatives for fibrosis, a 2026 systematic review has found.
Read more
5
Mins
28 Jul 2023
Intrahepatic Splenosis in a Patient with Hepatitis
Intrahepatic splenosis (IHS) is thought to be formed by the intrahepatic proliferation of splenic tissue by autograft after splenic injury…
3
Mins
27 Jul 2023
EASL 2023 Interview: Irene Bargellini
Interview: Irene Bargellini – Following your medical degree, what sparked your interest in oncologic imaging and later liver imaging? The…
7 Jul 2023
Outcomes No Different with Antibiotics in Child–Pugh A Cirrhosis
Stable patients with Child–Pugh A cirrhosis and acute variceal bleeding did not experience different outcomes after antibiotic prophylaxis…
7 Jul 2023
High Rates of Decompensation in Alcohol-Related Liver Disease
A new study investigates the clinical course of alcohol-related liver disease, considering that 15% of patients experience decompensation…
19 May 2023
The Future of Hepatitis Eradication
This podcast focuses on plans for the eradication of hepatitis B and C, as well as technological innovations and advances in hepatology
4
Mins
17 Apr 2023
Interview: Nancy Reau
My father always wanted me to be a doctor. He was a police officer and would come home late at night, talking about forensics and autopsies. My best friend in grade school had doctors for parents: a neurologist and neurosurgeon.
10
Mins
29 Mar 2023
Management of Clinically Significant Itch in Cholestatic Liver Disease
Cholestatic liver diseases include primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and progressive familial intrahepatic cholestasis (PFIC). In all of these conditions, cholestatic itch is a major symptom that can severely and chronically impact a person’s quality of life (QoL).
11
Mins
19 Dec 2022
Nothing About Me Without Me: Shared Decision-Making in Chronic Hepatitis B
Hepatitis B affects more than 296 million people worldwide, according to the World Health Organization (WHO). More than 1.5 million new infections occur each year, despite the availability of safe and effective vaccines.
Loading posts...
« Previous
1
…
38
39
40
41
42
…
76
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View